SCHEMBL7129899

SCHEMBL7129899

CC(C)(C)c1cc(NS(=O)(=O)c2cccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)c2)cc(C(C)(C)C)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
SMN1; SMN2 Q16637 5/20 0.55
MAPK1 P28482 3/20 0.55
HTT P42858 1/20 0.55
RORC P51449 6/20 0.54
MAPT P10636 2/20 0.54
CYP3A4 P08684 2/20 0.54
PPARG P37231 2/20 0.54
TP53 P04637 2/20 0.54
LMNA P02545 1/20 0.54
CYP1A2 P05177 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2C9 P11712 1/20 0.54
PKM P14618 1/20 0.54
TSHR P16473 1/20 0.54
NFKB1 P19838 1/20 0.54
CYP2C19 P33261 1/20 0.54
THPO P40225 1/20 0.54
MTOR P42345 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7132322 0.91 KMT2A (0.55) MEN1KMT2ASMN1; SMN2MAPK1HTT
SCHEMBL7124272 0.84 RORC (0.64) MEN1KMT2ASMN1; SMN2MAPK1RORC
SCHEMBL7121693 0.84 KMT2A (0.68) MEN1KMT2ASMN1; SMN2MAPK1HTT
SCHEMBL7120518 0.84 SMN1; SMN2 (0.61) MEN1KMT2ASMN1; SMN2MAPK1HTT
SCHEMBL7132438 0.82 RORC (0.71) MEN1KMT2ASMN1; SMN2MAPK1HTT
SCHEMBL27180767 0.79 MEN1 (0.77) MEN1KMT2ASMN1; SMN2MAPK1HTT
SCHEMBL7130303 0.79 KMT2A (0.62) MEN1KMT2ASMN1; SMN2MAPK1RORC
SCHEMBL7128804 0.78 MEN1 (0.74) MEN1KMT2ASMN1; SMN2MAPK1RORC
SCHEMBL27179770 0.77 MEN1 (0.71) MEN1KMT2ASMN1; SMN2MAPK1HTT
SCHEMBL7130551 0.76 RORC (0.82) MEN1KMT2ASMN1; SMN2MAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD MEN1 4865/4885KMT2A 3291/4885SMN1; SMN2 3743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.